GRI peer analysis
GRI Bio (GRI) against its competitors: price, today's move, 1-year return and market value side by side.
- GRI's peers: BDRX (Biodexa Pharmaceuticals), CANF (Can-Fite BioPharma), CLDI (Calidi Biotherapeutics), CNSP (CNS Pharmaceuticals), GNPX (Genprex), INM (InMed Pharmaceuticals), JAGX (Jaguar Health), SILO (Silo Pharma).
GRI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDRX Biodexa Pharmaceuticals | $1.95 | -2.26% | -98.74% | $181.86K |
| CANF Can-Fite BioPharma | $1.47 | -2.69% | -77.80% | $1.92M |
| CLDI Calidi Biotherapeutics | $0.51 | -4.23% | -97.88% | $1.74M |
| CNSP CNS Pharmaceuticals | $3.92 | -11.82% | -41.57% | $5.78M |
| GNPX Genprex | $1.67 | -2.34% | -97.73% | $843.24K |
| INM InMed Pharmaceuticals | $15.56 | 17.79% | 812.61% | – |
| JAGX Jaguar Health | $0.22 | -32.42% | -99.97% | $2.95M |
| SILO Silo Pharma | $1.88 | -0.53% | -68.27% | $4.05M |
| SXTP 60 Degrees Pharmaceuticals | $0.50 | -7.05% | -88.10% | $2.24M |
| GRI GRI Bio | $1.12 | -11.81% | -97.63% | $2.45M |